Vyhláška, kterou se mění vyhláška č. 532/2005 Sb., o úhradách léčiv a potravin pro zvláštní lékařské účely
| 42452 | MINIRIN 0.2 MG TABLETY | portbl nob30x0.2mg | FEG | S |
|---|---|---|---|---|
| 117.5 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1.00 |
| --- | --- | --- | --- | --- |
| 117.6 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1.00 |
| 117.7 | H01BA05 | ornipresin | parent. | 5.00 |
| 117.8 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15.00 |
| 117.9 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15.00 |
| 118 | hormony hypotalamu a jejich analoga | |||
| 118.1 | H01AX01 | pegvisomant | parent. | 10.00 |
| 118.2 | H01CA01 | gonadorelin (nasálně) | lok. | 1.20 |
| 118.3 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0.40 |
| 118.4 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0.40 |
| 118.5 | H01CB01 | somatostatin | parent. | 6.00 |
| 66824 | SOMATOSTATIN-UCB 3 MG | inf pso Iqf 1x3mg | UCB | B |
| --- | --- | --- | --- | --- |
| 118.6 | H01CB02 | oktreotid | parent. | 1.00 |
| --- | --- | --- | --- | --- |
| 118.7 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 10 mg | parent. | 357.00 |
| 118.8 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 20 mg | parent. | 714.00 |
| 118.9 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 30 mg | parent. | 1 072.00 |
| 118.10 | H01CB03 | lantreotid s obsahem 120mg | parent. | 4.29 |
| 118.11 | H01CB03 | lantreotid s obsahem 30mg | parent. | 2.14 |
| 118.12 | H01CB03 | lantreotid s obsahem 60mg | parent. | 2.14 |
| 118.13 | H01CB03 | lantreotid s obsahem 90mg | parent. | 3.21 |
| 118.14 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu) | parent. | 0.25 |
| 118.15 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0.25 |
| 118.16 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0.25 |
| 119 | kortikosteroidy pro celkové použití, perorální podání | |||
| 119.1 | H02AA02 | fludrokortison | p.o. | 0.10 |
| 119.2 | H02AB01 | betamethason | p.o. | 1.50 |
| 119.3 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.50 |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D |
| --- | --- | --- | --- | --- |
| 119.4 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.50 |
| --- | --- | --- | --- | --- |
| 119.5 | H02AB07 | prednison | p.o. | 10.00 |
| 02963 | PREDNISON 20 LÉČIVA | tbl 20x20mg-blistr | ZEH | CZ |
| --- | --- | --- | --- | --- |
| 119.6 | H02AB08 | triamcinolon | p.o. | 7.50 |
| --- | --- | --- | --- | --- |
| 119.7 | H02AB09 | hydrokortison | p.o. | 30.00 |
| 76205 | HYDROCORTISON 10 MG JENAPHARM | por tbl nob 20x10mg | VJP | D |
| --- | --- | --- | --- | --- |
| 119.8 | H02AB10 | kortison | p.o. | 37.50 |
| --- | --- | --- | --- | --- |
| 120 | kortikosteroidy pro celkové použití, ostatní cesty aplikace | |||
| 120.1 | H02AB | mazipredon | parent. | 30.00 |
| 120.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.40 |
| 120.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.50 |
| 120.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.50 |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY |
| --- | --- | --- | --- | --- |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY |
| 120.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20.00 |
| --- | --- | --- | --- | --- |
| 120.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20.00 |
| 120.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20.00 |
| 120.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10.00 |
| 120.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10.00 |
| 120.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10.00 |
| 120.11 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10.00 |
| 120.12 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10.00 |
| 120.13 | H02AB08 | triamcinolon | parent. | 7.50 |
| 120.14 | H02AB09 | hydrokortison | parent. | 30.00 |
| 121 | hormony štítné žlázy a jódová terapie | |||
| 121.1 | H03AA | hormony štítné žlázy | p.o. | 1.00 |
| 61160 | JODTHYROX | tbl 50 | MEC | D |
| --- | --- | --- | --- | --- |
| 121.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 |
| --- | --- | --- | --- | --- |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D |
| --- | --- | --- | --- | --- |
| 121.3 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 |
| --- | --- | --- | --- | --- |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D |
| --- | --- | --- | --- | --- |
| 121.4 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 |
| --- | --- | --- | --- | --- |
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D |
| --- | --- | --- | --- | --- |
| 121.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 |
| --- | --- | --- | --- | --- |
| 121.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1.00 |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D |
| --- | --- | --- | --- | --- |
| 121.7 | H03CA | jódová terapie | p.o. | 200.00 |
| --- | --- | --- | --- | --- |
| 61158 | JODID 100 | tbl 100 | MEC | D |
| --- | --- | --- | --- | --- |
| 122 | Tyreostatika | |||
| --- | --- | --- | --- | --- |
| 122.1 | H03BA02 | propylthiouracil | p.o. | 0.10 |
| 14914 | PROPYCIL 50 | por tblnob100x50mg | HPB | D |
| --- | --- | --- | --- | --- |
| 122.2 | H03BB01 | karbimazol | p.o. | 15.00 |
| --- | --- | --- | --- | --- |
| 00066 | CARBIMAZOL-SLOVAKOFARMA | tbl 100x5mg | ZEH | SK |
| --- | --- | --- | --- | --- |
| 122.3 | H03BB02 | thiamazol | p.o. | 10.00 |
| --- | --- | --- | --- | --- |
| 122.4 | H03BB02 | thiamazol | parent. | 10.00 |
| 122.5 | H03BC01 | perchlorát draselný | p.o. | 0.20 |
| 123 | glukagon a homeostatika vápníku a ostatní hormonální léčiva | |||
| 123.1 | H04AA01 | glukagon | parent. | 1.00 |
| 123.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1.00 |
| 83741 | GLUCAGEN 1 MG HYPOKIT | inj sic 1mg+sol+stŘ | NOO | DK |
| --- | --- | --- | --- | --- |
| 123.3 | H05AA02 | teriparatid | parent. | 20.00 |
| --- | --- | --- | --- | --- |
| 123.4 | H05BA01 | kalcitonin (lososí) | parent. | 100.00 |
| 123.5 | H05BA01 | kalcitonin (lososí) | inhal. | 200.00 |
Kalcitonin předepisuje internista, ortoped, revmatolog, gynekolog a endokrinolog u osteoporózy prokázané celotělovým denzitometrem (méně než -2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii. Po 3 měsících je vyhodnocen efekt léčby. Pokud došlo k ústupu algického syndromu, je možno pokračovat v další léčbě po dobu maximálně 6 měsíců.
| 123.6 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100.00 | U | 122,52 | L/INT,ORT, END,GER |
|---|---|---|---|---|---|---|---|
| 123.7 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100.00 | U | 153,82 | L/INT,ORT, END,GER |
| 123.8 | H05BX01 | cinacalcet | p.o. | 60.00 | MG | 392,45 | X |
| 124 | ostatní léčiva ze skupiny hormonů | ||||||
| 124.1 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.50 | MG | 3,34 | |
| 124.2 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.50 | MG | 4,68 | |
| 86606 | MEDROL 16 MG | por tblnob50x16mg-b | PMB | B | |||
| --- | --- | --- | --- | --- | |||
| 125 | tetracyklinová a amfenikolová antibiotika | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 125.1 | J01AA02 | doxycyklin | p.o. | 0.10 | GM | 3,83 | |
| 04013 | DOXYBENE 200 MG TABLETY | por tbl nob10x200mg | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D | |||
| 12738 | DOXYHEXAL 200 TABS | tbl 20x200mg | SFS | D | |||
| 32953 | DOXYHEXAL TABS | tbl 10x100mg | SFS | D | |||
| 32954 | DOXYHEXAL TABS | tbl 20x100mg | SFS | D | |||
| 47718 | DOXYCYCLIN AL 100 | tbl 10x100mg | APA | D | |||
| 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D | |||
| 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D | |||
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | |||
| 125.2 | J01AA02 | doxycyklin | parent. | 0.10 | GM | 89,21 | K |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 125.3 | J01AA04 | lymecyklin | p.o. | 0.60 | GM | 3,83 | |
| 125.4 | J01AA06 | oxytetracyklin | p.o. | 1.00 | GM | 3,83 | |
| 125.5 | J01AA07 | tetracyklin | p.o. | 1.00 | GM | 3,83 | |
| 125.6 | J01AA08 | minocyklin | p.o. | 0.20 | GM | 7,66 | |
| 125.7 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 92,48 | K |
| 125.8 | J01AA | doxycyklin v kombinaci s ambroxolem | p.o. | 1.00 | DF | 6,03 | |
| 125.9 | J01BA01 | chloramfenikol | p.o. | 3.00 | GM | 25,29 | |
| 125.10 | J01BA01 | chloramfenikol | parent. | 3.00 | GM | 261,85 | K |
| 125.11 | J01BA02 | thiamphenikol | parent. | 1.50 | GM | 172,31 | K |
| 126 | peniciliny se širokým spektrem, perorální podání | ||||||
| 126.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2.00 | GM | 13,81 | |
| 126.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2.00 | GM | 16,81 | |
| 126.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1.00 | GM | 9,87 | |
| 15896 | APO-AMOXI 500 | por cps dur30x500mg | CMG | IRL | |||
| --- | --- | --- | --- | --- | |||
| 17628 | AMOXIHEXAL 500 | tbl obd 10x500mg | SFS | D | |||
| 17629 | AMOXIHEXAL 500 | tbl obd 20x500mg | SFS | D | |||
| 19503 | APO-AMOXI 500 | por cps dur30x500mg | KAT | NL | |||
| 32557 | OSPAMOX 500 MG | por tbl flm14x500mg | SZK | A | |||
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | |||
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | |||
| 66364 | OSPAMOX 250MG | cps 12x250mg | SZK | A | |||
| 66368 | OSPAMOX 500 MG | por tbl flm 12x500mg | SZK | A | |||
| 126.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1 tabletě | p.o. | 1.00 | GM | 8,85 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17623 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 17624 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | SFS | D | |||
| 17625 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | SFS | D | |||
| 17630 | AMOXIHEXAL 750 | tbl obd 10x750mg | SFS | D | |||
| 17631 | AMOXIHEXAL 750 | tbl obd 20x750mg | SFS | D | |||
| 17632 | AMOXIHEXAL 750 | tbl obd 50x750mg | SFS | D | |||
| 32558 | OSPAMOX 750 MG | por tbl flm 14x750mg | SZK | A | |||
| 32559 | OSPAMOX 1000 MG | por tblflm14x1000mg | SZK | A | |||
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | |||
| 44340 | AMOXIHEXAL 750 | tbl obd 20x750mg | HHC | D | |||
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | |||
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | |||
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | |||
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | |||
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | |||
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | |||
| 66369 | OSPAMOX 750 MG | por tbl flm 12x750mg | SZK | A | |||
| 66370 | OSPAMOX 1000 MG | por tblflm12x1000mg | SZK | A | |||
| 126.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1.00 | GM | 11,41 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17620 | AMOXIHEXAL | plv sus 1x100ml | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 17622 | AMOXIHEXAL FORTE | plv sus 1x100ml | SFS | D | |||
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | |||
| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D | |||
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | |||
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | SZK | A | |||
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | SZK | A | |||
| 126.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1.00 | GM | 9,77 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17626 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 17627 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | SFS | D | |||
| 17633 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | SFS | D | |||
| 17634 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | SFS | D | |||
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | |||
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | |||
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | |||
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | |||
| 126.7 | J01CA06 | bakampicilin | p.o. | 1.20 | GM | 16,24 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 127 | peniciliny se širokým spektrem, ostatní cesty aplikace | ||||||
| 127.1 | J01CA01 | ampicilin | parent. | 2.00 | GM | 42,37 | K |
| 86197 | AMPICILIN 0.5 BIOTIKA | inj sic 50x500mg | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 127.2 | J01CA09 | azlocilin | parent. | 12.00 | GM | 623,01 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 127.3 | J01CA12 | piperacilin | parent. | 14.00 | GM | 1 268,52 | U/ATB |
| 127.4 | J01CA13 | tikarcilin | parent. | 15.00 | GM | 1 935,95 | U/ATB |
| 127.5 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2.00 | GM | 142,64 | U/ATB |
| 127.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1.00 | GM | 95,69 | U/ATB |
| 127.7 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15.00 | GM | 1 576,70 | U/ATB |
| 93170 | TIMENTIN 3.2 GM | inj sic 4x3.2gm | SKW | GB | |||
| --- | --- | --- | --- | --- | |||
| 127.8 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14.00 | GM | 1 742,35 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 127.9 | J01CR50 | kombinace penicilinů | parent. | 3.00 | DF | 70,17 | U |
| 128 | peniciliny citlivé k betalaktamáze, perorální podání | ||||||
| 128.1 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2.00 | GM | 17,54 | |
| 45996 | OSPEN 500 | por tblflm30x500ku | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob30x800ku | BTA | SK | |||
| 92806 | V-PENICILIN 500 MG SLOVAKOFARMA | tbl 30x500mg-blistr | ZEH | SK | |||
| 128.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2.00 | GM | 19,30 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob30x400ku | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | ZEH | SK | |||
| 128.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2.00 | GM | 16,47 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-bli | ZEH | SK | |||
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-bli | ZEH | SK | |||
| 45997 | OSPEN 1000 | por tblflm30x1000ku | SZK | A | |||
| 45998 | OSPEN 1500 | por tblflm30x1500ku | SZK | A | |||
| 49513 | PENBENE 1 000 000 | tbl obd 30x1mu | MCK | D | |||
| 57778 | PENBENE 1 500 000 | tbl obd 21 | MCK | D | |||
| 65356 | PENBENE 1 000 000 | tbl obd 12x1mu | MCK | D | |||
| 66359 | OSPEN 1000 | por tblflm12x1000ku | SZK | A | |||
| 66360 | OSPEN 1500 | por tblflm12x1500ku | SZK | A | |||
| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob30x1.2mu | BTA | SK | |||
| 128.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2.00 | GM | 68,40 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 128.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2.00 | GM | 25,70 | |
| 128.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 13,87 | |
| 56442 | PENCLEN | tbl 30x350mg-bli | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 128.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2.00 | GM | 25,32 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 49549 | OSPEN 400 | sir 1x150ml | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 76213 | OSPEN 750 KRKA | por sus 1x60ml/9gm | KRK | SLO | |||
| 129 | peniciliny citlivé k betalaktamáze, ostatní cesty aplikace | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 129.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.60 | GM | 118,54 | K |
| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10x1mu | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 129.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.60 | GM | 47,95 | K |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10x5mu | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 129.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.00 | MU | 69,03 | K |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 129.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.00 | MU | 26,32 | K |
| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 129.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2.00 | MU | 77,77 | K |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 129.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2.00 | MU | 37,96 | K |
| 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10x1.5mu | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 129.7 | J01CE30 | kombinace | parent. | 0.50 | DF | 10,08 | K |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02723 | PENDEPON COMPOSITUM | inj sic 10x1.5mu | BTA | SK | |||
| --- | --- | --- | --- | --- | |||
| 130 | peniciliny rezistentní k betalaktamáze a kombinace penicilinů včetně inhibitorů betalaktamáz, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 130.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28,09 | |
| 130.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 | |
| 130.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28,09 | |
| 130.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 | |
| 130.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1.00 | GM | 28,00 | |
| 130.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 1 g v 1 tabletě) | p.o. | 1.00 | GM | 18,14 | |
| 130.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1.00 | GM | 25,53 | |
| 130.8 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg do 1 g v 1 tabletě včetně) | p.o. | 1.00 | GM | 23,95 | |
| 130.9 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1.00 | GM | 36,77 | |
| 130.10 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1.00 | GM | 27,85 | |
| 44793 | AUGMENTIN DUO | por plv sus 1x140ml | SKW | GB | |||
| --- | --- | --- | --- | --- | |||
| 84792 | AUGMENTIN DUO | por plv sus 1x70ml | SKW | GB | |||
| 130.11 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.50 | GM | 71,66 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17149 | UNASYN | por tbl flm 12x375mg | PFI | I | |||
| --- | --- | --- | --- | --- | |||
| 72881 | UNASYN | tbl obd 12x375mg | PFI | TR | |||
| 130.12 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.50 | GM | 75,11 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 131 | jiná betalaktamová antibiotika, perorální podání | ||||||
| 131.1 | J01DB01 | cefalexin (pevné lékové formy) | p.o. | 2.00 | GM | 37,26 | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 131.2 | J01DB01 | cefalexin (tekuté lékové formy) | p.o. | 2.00 | GM | 38,63 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | SZK | A | |||
| 131.3 | J01DC02 | cefuroxim axetil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 18499 | XORIMAX 125 MG POTAH.TABLETY | portblflm 10x125mg | SZK | A | |||
| --- | --- | --- | --- | --- | |||
| 18523 | XORIMAX 250 MG POTAH.TABLETY | portblflm 10x250mg | SZK | A | |||
| 18547 | XORIMAX 500 MG POTAH.TABLETY | portblflm 10x500mg | SZK | A | |||
| 131.4 | J01DC02 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 131.5 | J01DC04 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 56,15 | |
| 16450 | VERCEF 250 MG | cps 3x7=21 bli | IRI | IRL | |||
| --- | --- | --- | --- | --- | |||
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RDD | IND | |||
| 131.6 | J01DC04 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.50 | GM | 52,58 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 131.7 | J01DC04 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.50 | GM | 82,09 | |
| 131.8 | J01DC04 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.50 | GM | 68,61 | |
| 131.9 | J01DB05 | cefadroxil (pevné lékové formy) | p.o. | 2.00 | GM | 37,26 | |
| 131.10 | J01DB05 | cefadroxil (tekuté lékové formy) | p.o. | 2.00 | GM | 39,99 | |
| 131.11 | J01DD08 | cefixim | p.o. | 0.40 | GM | 88,93 | ATB |
| 131.12 | J01DD10 | cefetamet | p.o. | 1.00 | GM | 88,93 | ATB |
| 131.13 | J01DD13 | cefpodoxim | p.o. | 0.40 | GM | 85,74 | ATB |
| 131.14 | J01DD14 | ceftibuten | p.o. | 0.40 | GM | 85,74 | ATB |
| 131.15 | J01DC10 | cefprozil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 | |
| 131.16 | J01DC10 | cefprozil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |
| 132 | jiná betalaktamová antibiotika, ostatní cesty aplikace | ||||||
| 132.1 | J01CF04 | oxacilin | parent. | 2.00 | GM | 93,63 | K |
| 132.2 | J01DD62 | cefoperazon a inhibitor beta-laktamázy | parent. | 2.00 | GM | 387,99 | U/ATB |
| 132.3 | J01DB03 | cefalotin | parent. | 4.00 | GM | 122,33 | U/ATB |
| 132.4 | J01DB04 | cefazolin | parent. | 3.00 | GM | 118,18 | U/ATB |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | |||
| --- | --- | --- | --- | --- | |||
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | |||
| 132.5 | J01DC01 | cefoxitin | parent. | 6.00 | GM | 916,50 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.6 | J01DC02 | cefuroxim | parent. | 4.00 | GM | 321,63 | U/ATB |
| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | |||
| --- | --- | --- | --- | --- | |||
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | |||
| 64835 | AXETINE 750 MG | inj sic 10x750mg | MOE | CY | |||
| 64837 | AXETINE 750 MG | inj sic 100x750mg | MOE | CY | |||
| 132.7 | J01DC04 | cefamandol | parent. | 6.00 | GM | 562,21 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.8 | J01DD01 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6.00 | GM | 466,60 | U/ATB |
| 15669 | CEFTAX 1000 | inj sic 1x1000mg | HIK | P | |||
| --- | --- | --- | --- | --- | |||
| 49193 | CEFTAX 1000 | inj plvsol10x1000mg | HIK | P | |||
| 83050 | SEFOTAK 1 G | inj plv sol 1x1gm | ICZ | CZ | |||
| 132.9 | J01DD01 | cefotaxim nad 1 g v jedné ampuli | parent. | 6.00 | GM | 430,56 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.10 | J01DD02 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6.00 | GM | 1 696,77 | U/ATB |
| 132.11 | J01DD02 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6.00 | GM | 1 641,30 | U/ATB |
| 76353 | FORTUM 1 G | inj plv sol 1x1gm | GWE | I | |||
| --- | --- | --- | --- | --- | |||
| 76354 | FORTUM 2 G | inj plv sol 1x2gm | GWE | I | |||
| 132.12 | J01DD03 | cefsulodin | parent. | 6.00 | GM | 601,70 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.13 | J01DD04 | ceftriaxon | parent. | 2.00 | GM | 497,05 | ambulantně: K/P ústavně: U/ATB |
Léčbu ceftriaxonem v ambulantní péči předepisuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog k:
- a) iniciální léčbě bakteriální meningitidy u dětí mladších 18 let,
- b) léčbě Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčbě nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 58756 | CEFTRIAXON TORREX 2 G | inj plv sol 1x2gm | TRX | A |
|---|---|---|---|---|
| 132.14 | J01DD07 | ceftizoxim | parent. | 4.00 |
| --- | --- | --- | --- | --- |
| 132.15 | J01DE01 | cefepim | parent. | 4.00 |
| 132.16 | J01DB08 | cefapirin | parent. | 4.00 |
| 132.17 | J01DD12 | cefoperazon | parent. | 6.00 |
| 132.18 | J01DE02 | cefpirom | parent. | 4.00 |
| 132.19 | J01DF01 | aztreonam | parent. | 4.00 |
| 132.20 | J01DH | ertapenem | parent. | 1.00 |
| 132.21 | J01DH02 | meropenem | parent. | 2.00 |
| 132.22 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2.00 |
| 133 | sulfonamidy a trimetoprim | |||
| 133.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.40 |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D |
| --- | --- | --- | --- | --- |
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D |
| 133.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.40 |
| --- | --- | --- | --- | --- |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D |
| --- | --- | --- | --- | --- |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D |
| 133.3 | J01EB05 | sulfafurazol | p.o. | 4.00 |
| --- | --- | --- | --- | --- |
| 133.4 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 |
| 133.5 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D |
| --- | --- | --- | --- | --- |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D |
| 133.6 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 |
| --- | --- | --- | --- | --- |
| 133.7 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 |
| 133.8 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 |
| 133.9 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 |
| 133.10 | J01EE04 | sulfamoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 |
| 133.11 | J01EE04 | sulfamoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 |
| 133.12 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 |
| 134 | makrolidová antibiotika a jejich kombinace s antibakteriálními léčivy | |||
| 134.1 | J01FA | telithromycin | p.o. | 800.00 |
| 134.2 | J01FA01 | erythromycin | parent. | 1.00 |
| 134.3 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1.00 |
| 134.4 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1.00 |
| 55585 | MEROMYCIN | plv sus 1x100ml | MCK | D |
| --- | --- | --- | --- | --- |
| 134.5 | J01FA02 | spiramycin | p.o. | 3.00 |
| --- | --- | --- | --- | --- |
| 134.6 | J01FA02 | spiramycin | parent. | 4.50 |
| 17129 | ROVAMYCINE PLV.PRO INF.1.5 MIU | plv inf 1x1.5mu | AVM | F |
| --- | --- | --- | --- | --- |
| 134.7 | J01FA05 | oleandomycin | p.o. | 1.00 |
| --- | --- | --- | --- | --- |
| 134.8 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.30 |
| 134.9 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.30 |
| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 10x150mg | MCK | D |
| --- | --- | --- | --- | --- |
| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm14x150mg | MCK | D |
| 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG | por tbl flm 10x300mg | MCK | D |
| 134.10 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2.00 |
| --- | --- | --- | --- | --- |
| 134.11 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1.00 |
| 134.12 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.50 |
| 134.13 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.50 |
| 134.14 | J01FA09 | klaritromycin | parent. | 1.00 |
| 134.15 | J01FA10 | azithromycin (pevné lékové formy) | p.o. | 0.30 |
| 134.16 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.30 |
| 134.17 | J01FA10 | azitromycin | parent. | 0.50 |
| 134.18 | J01FA13 | dirythromycin | p.o. | 0.50 |
| 134.19 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1.00 |
| 134.20 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5.00 |
| 135 | linkosamidová antibiotika | |||
| 135.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.80 |
| 135.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.80 |
| 135.3 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.20 |
| 135.4 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.20 |
| 135.5 | J01FF02 | linkomycin | parent. | 1.80 |
| 135.6 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.80 |
| 91997 | NELOREN | cps 16x500mg | LEK | SLO |
| --- | --- | --- | --- | --- |
| 135.7 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.80 |
| --- | --- | --- | --- | --- |
| 136 | aminoglykosidová antibiotika | |||
| 136.1 | J01GA01 | streptomycin | parent. | 1.00 |
| 13797 | STREPTOMYCIN 1GM | plv sol 10x1gm/lahv | BAK | BG |
| --- | --- | --- | --- | --- |
| 136.2 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 |
| --- | --- | --- | --- | --- |
| 136.3 | J01GB01 | tobramycin (léková forma – inhalační roztok) | inhal. | 0.60 |
Tobramycin v inhalační formě je indikován u pacientů s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.
| 136.4 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 22,50 | U/ATB |
|---|---|---|---|---|---|---|---|
| 136.5 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 44,15 | U/ATB |
| 136.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1.00 | DF | 148,61 | U/ATB |
| 136.7 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130.00 | MG | 2 357,23 | U/ATB |
| 136.8 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,07 | U/ATB |
| 136.9 | J01GB05 | neomycin | parent. | 1.00 | GM | 119,56 | U/ATB |
| 136.10 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | GM | 651,76 | U/ATB |
| 136.11 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1.00 | GM | 350,66 | U/ATB |
| 136.12 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 508,13 | U/ATB |
| 136.13 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 297,66 | U/ATB |
| 136.14 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1.00 | GM | 606,19 | U/ATB |
| 136.15 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1.00 | GM | 505,17 | U/ATB |
| 137 | chinolonová chemoterapeutika | ||||||
| 137.1 | J01MA | trovafloxacin | p.o. | 0.20 | GM | 23,94 | P |
K léčbě trovafloxacinem je třeba konzultace a schválení antibiotického střediska.
| 137.2 | J01MA | trovafloxacin | parent. | 0.20 | GM | 207,41 | U/ATB |
|---|---|---|---|---|---|---|---|
| 137.3 | J01MA01 | ofloxacin | p.o. | 0.40 | GM | 18,57 | |
| 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND | |||
| --- | --- | --- | --- | --- | |||
| 17412 | ZANOCIN 200MG | tbl obd 10x200mg | IRI | IRL | |||
| 137.4 | J01MA01 | ofloxacin | parent. | 0.40 | GM | 207,41 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.5 | J01MA02 | ciprofloxacin | p.o. | 1.00 | GM | 18,57 | |
| 15653 | CIPLOX 250 | tbl obd 10x250mg | SDD | CZ | |||
| --- | --- | --- | --- | --- | |||
| 15654 | CIPLOX 250 | tbl obd 50x250mg | SDD | CZ | |||
| 15658 | CIPLOX 500 | tbl obd 10x500mg | SDD | CZ | |||
| 15659 | CIPLOX 500 | tbl obd 50x500mg | SDD | CZ | |||
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | |||
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | |||
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | |||
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | |||
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | |||
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | |||
| 137.6 | J01MA02 | ciprofloxacin – infúze | parent. | 0.50 | GM | 207,41 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 15651 | CIPLOX | inf 1x100ml(plast) | SDD | CZ | |||
| --- | --- | --- | --- | --- | |||
| 56830 | CIPLOX | inf 1x100ml(plast) | CIA | IND | |||
| 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO | |||
| 137.7 | J01MA02 | ciprofloxacin – injekce | parent. | 0.50 | GM | 182,60 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 96040 | CIPRINOL 100MG/10ML | inf 5x10ml/100mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 137.8 | J01MA03 | pefloxacin | p.o. | 0.80 | GM | 18,57 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.9 | J01MA03 | pefloxacin | parent. | 0.80 | GM | 91,14 | U/ATB |
| 137.10 | J01MA04 | enoxacin | p.o. | 0.80 | GM | 18,57 | |
| 137.11 | J01MA06 | norfloxacin | p.o. | 0.80 | GM | 18,57 | |
| 01660 | NORFLOXACIN-RATIOPHARM 400MG | por tblflm 20x400mg | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 42549 | NORFLOXACIN-RATIOPHARM 400MG | por tblflm 14x400mg | MCK | D | |||
| 44090 | GYRABLOCK 400 | por tblflm500x400mg | MOE | CY | |||
| 44091 | GYRABLOCK 400 | portblflm 1000x400mg | MOE | CY | |||
| 93465 | NOLICIN | tbl obd 20x400mg | KRK | SLO | |||
| 137.12 | J01MA07 | lomefloxacin | p.o. | 0.80 | GM | 18,57 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.13 | J01MA08 | fleroxacin | p.o. | 0.40 | GM | 18,57 | |
| 137.14 | J01MA08 | fleroxacin | parent. | 0.40 | GM | 207,41 | U/ATB |
| 137.15 | J01MA09 | sparfloxacin | p.o. | 0.20 | GM | 18,57 | P |
K léčbě sparfloxacinem je třeba konzultace a schválení antibiotického střediska.
| 137.16 | J01MA12 | levofloxacin | parent | 0.25 | GM | 207,31 | U/ATB |
|---|---|---|---|---|---|---|---|
| 137.17 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 73,30 | U/ATB |
| 137.18 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0.25 | GM | 58,64 | U/ATB |
| 137.19 | J01MA14 | moxifloxacin | p.o. | 0.40 | GM | 58,64 | U/ATB |
| 138 | ostatní antibiotika či chemoterapeutika, včetně močových chemoterapeutik | ||||||
| 138.1 | J01XA01 | vankomycin | parent. | 2.00 | GM | 1 122,92 | U/ATB |
| 138.2 | J01XA02 | teikoplanin | parent. | 0.40 | GM | 2 192,57 | U/ATB |
| 138.3 | J01XB01 | kolistin | p.o. | 3.00 | MU | 41,85 | U/ATB |
| 138.4 | J01XB01 | kolistin | parent. | 3.00 | MU | 106,86 | U/ATB |
| 138.5 | J01XB02 | polymyxin | parent. | 0.15 | GM | 100,75 | U/ATB |
| 138.6 | J01XX08 | linezolid | p.o. | 1.20 | GM | 4 702,75 | U/ATB |
| 03902 | ZYVOXID | por tbl flm 10x600mg | PMB | B | |||
| --- | --- | --- | --- | --- | |||
| 138.7 | J01XX08 | linezolid | parent | 1.20 | GM | 4 633,89 | U/ATB |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 03708 | ZYVOXID | inf sol 10x300ml | FRK | N | |||
| --- | --- | --- | --- | --- | |||
| 139 | imidazolová chemoteraputika pro celkové použití a jiné antibakteriální látky | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 139.1 | G01AX05 | nifuratel | p.o. | 0.60 | GM | 12,22 | |
| 139.2 | J01XD01 | metronidazol | p.o. | 2.00 | GM | 13,03 | |
| 02427 | ENTIZOL | tbl 20x250mg | ZPF | PL | |||
| --- | --- | --- | --- | --- | |||
| 139.3 | J01XD01 | metronidazol | p.rect. | 2.00 | GM | 8,17 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 139.4 | J01XD01 | metronidazol | parent. | 1.50 | GM | 167,02 | U |
| 81678 | METRONIDAZOL-SERAG | inf sol 1x100ml | SWS | D | |||
| --- | --- | --- | --- | --- | |||
| 139.5 | J01XD02 | tinidazol | p.o. | 2.00 | GM | 13,49 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 139.6 | J01XD03 | ornidazol | p.o. | 1.50 | GM | 21,50 | |
| 139.7 | J01XD03 | ornidazol | parent. | 1.00 | GM | 49,30 | U |
| 139.8 | J01XE01 | nitrofurantoin | p.o. | 0.20 | GM | 6,42 | |
| 140 | antimykotika pro systémové užití | ||||||
| 140.1 | D01BA01 | griseofulvin | p.o. | 0.50 | GM | 9,74 | |
| 140.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 30,78 | L/DER |
| 140.3 | J02AA01 | amfotericin | parent. | 35.00 | MG | 273,02 | U |
| 140.4 | J02AA01 | amfotericin na tukových nosičích | parent. | 35.00 | MG | 1 483,35 | U/ATB |
| 140.5 | J02AB01 | mikonazol | parent. | 1.00 | GM | 458,97 | U |
| 140.6 | J02AB02 | ketokonazol | p.o. | 0.20 | GM | 14,66 | |
| 140.7 | J02AC01 | flukonazol | parent. | 0.20 | GM | 537,52 | U/P |
Parenterální flukonazol je indikován v indikaci léčby těžké, život ohrožující systémové mykózy. Profylakticky: u imunokompromitovaných pacientů nebo pacientů připravovaných k transplantaci.
| 58431 | DIFLAZON | inf sol 1x100ml | KRK | SLO |
|---|---|---|---|---|
| 65989 | MYCOMAX INF | inf 1x100ml/200mg | ZEH | CZ |
| 140.8 | J02AC01 | flukonazol – ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.20 |
| --- | --- | --- | --- | --- |
| 16638 | MYKOHEXAL 100 | por cpsdur 28x100mg | SFS | D |
| --- | --- | --- | --- | --- |
| 66032 | MYCOMAX 50 | cps 7x50mg | ZEH | CZ |
| 66033 | MYCOMAX 50 | cps 28x50mg | ZEH | CZ |
| 66036 | MYCOMAX 100 | cps 28x100mg | ZEH | CZ |
| 66037 | MYCOMAX 100 | cps 7x100mg | ZEH | CZ |
| 140.9 | J02AC01 | flukonazol – tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.20 |
| --- | --- | --- | --- | --- |
| 140.10 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě) | p.o. | 0.15 |
| 10689 | FORCAN-150 | por cps dur 1x150mg | CIA | IND |
| --- | --- | --- | --- | --- |
| 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H |
| 16396 | FORCAN-150 | por cps dur 1x150mg | SDD | CZ |
| 31800 | MYKOHEXAL 150 | por cps dur 1x150mg | SFS | D |
| 47439 | MYCOMAX 150 | por cps dur 3x150mg | ZEH | CZ |
| 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO |
| 59875 | MYCOSYST 150 MG | cps 1x150mg | GED | H |
| 59876 | MYCOSYST 150 MG | cps 2x150mg | GED | H |
| 66039 | MYCOMAX 150 | por cps dur 1x150mg | ZEH | CZ |
| 140.11 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.20 |
| --- | --- | --- | --- | --- |
| 64950 | DIFLUCAN 50MG/5ML | plv sus 1x35ml | PFC | F |
| --- | --- | --- | --- | --- |
| 140.12 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.20 |
| --- | --- | --- | --- | --- |
| 140.13 | J02AC02 | itrakonazol | parent. | 0.20 |
| 140.14 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.20 |
| 140.15 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.20 |
| 140.16 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.20 |
| 140.17 | J02AC03 | vorikonazol | p.o. | 0.40 |
| 140.18 | J02AC03 | vorikonazol | parent. | 0.40 |
| 140.19 | J02AX01 | flucytosin | p.o. | 10.00 |
Perorální flukonazol, itrakonazol a flucytosin pro krátkodobou léčbu předepisuje gynekolog nebo dermatolog na základě kultivačního nebo mikroskopického vyšetření u:
- a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika,
- b) recidivy vaginálních mykóz.
Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog u:
- a) systémových mykóz u imunokompromitovaných pacientů,
- b) těžké formy slizničních a kožních mykóz vyvolaných kandidami nebo dermatofyty na základě kultivačního nebo mikroskopického vyšetření,
- c) těžké formy nehtových mykóz (itrakonazol), v indikacích, kde nelze použít terbinafin a platí-li alespoň jedna z následujících podmínek:
1) postižení celé nehtové ploténky,
2) postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem,
3) postižení nehtu palce dolní končetiny.
Podmínkou zahájení léčby ad c) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.
Profylakticky u imunokompromitovaných pacientů nebo u pacientů před provedením transplantace.
Itrakonazol v tekutých lékových formách je indikován k léčbě orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů.
| 140.20 | J02AX01 | flucytosin | parent. | 10.00 | GM | 2 649,29 | U/P |
|---|---|---|---|---|---|---|---|
Parenterální flucytosin je indikován v indikaci léčby těžké, život ohrožující systémové mykózy.
Profylakticky: u imunokompromitovaných pacientů včetně pacientů připravovaných k transplantaci.
| 140.21 | J02AX04 | caspofungin s obsahem 50 mg v jedné ampulce | parent. | 1.00 | DF | 16 867,22 | U/ATB |
|---|---|---|---|---|---|---|---|
| 140.22 | J02AX04 | caspofungin s obsahem 70 mg v jedné ampulce | parent. | 1.00 | DF | 23 614,50 | U/ATB |
| 141 | ostatní antimykobakteriální látky | ||||||
| 141.1 | J04AB02 | rifampicin | p.o. | 0.60 | GM | 12,47 | |
| 48463 | ARFICIN 300 MG | cps 100x300mg | BUO | SK | |||
| --- | --- | --- | --- | --- | |||
| 141.2 | J04AB03 | rifamycin | parent. | 0.60 | GM | 238,85 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 141.3 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 111,11 | P |
Léčbu rifabutinem předepisuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
| 91946 | MYCOBUTIN 150 | cps 30x150mg | PHA | I |
|---|---|---|---|---|
| 141.4 | J04AB30 | kapreomycin | parent. | 1.00 |
| --- | --- | --- | --- | --- |
| 141.5 | J04AC01 | Isoniazid | p.o. | 0.30 |
| 141.6 | J04AK01 | pyrazinamid | p.o. | 1.50 |
| 141.7 | J04AK02 | ethambutol | p.o. | 1.20 |
| 141.8 | J04BA02 | dapson | p.o. | 50.00 |
| 142 | systémová antivirotika pro léčbu herpetických, cytomegalovirových infekcí a některých dalších virových infekcí |
Léčbu famciklovirem, valaciklovirem, brivudinem a parenterálním aciklovirem předepisuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:
- a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,
- b) léčba herpes zoster a herpes genitalis u imunokompromitovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),
- c) profylaxe po alogenní transplantaci kostní dřeně.
| 142.1 | J05AB01 | aciklovir | parent. | 4.00 | GM | 1 405,65 | U/P |
|---|---|---|---|---|---|---|---|
| 142.2 | J05AB01 | aciklovir do 200 mg včetně | p.o. | 4.00 | GM | 195,17 | |
| 142.3 | J05AB01 | aciklovir nad 200 mg | p.o. | 4.00 | GM | 171,52 | |
| 142.4 | J05AB01 | aciklovir (suspense) | p.o. | 4.00 | GM | 265,83 | P |
Aciklovir suspenze je indikován u dětí v indikaci herpes zoster.
| 142.5 | J05AB04 | ribavirin | p.o. | 1.00 | GM | 591,23 | X |
|---|---|---|---|---|---|---|---|
| 142.6 | J05AB06 | ganciklovir | p.o. | 3.00 | GM | 1 819,79 | P |
| 142.7 | J05AB06 | ganciklovir | parent. | 0.50 | GM | 1 456,43 | U/P |
| 02064 | CYMEVENE | inf sic 1x500mg | HLR | CH | |||
| --- | --- | --- | --- | --- | |||
| 16547 | CYMEVENE | inf sic 1x500mg | RCE | CZ | |||
| 142.8 | J05AB09 | famciklovir | p.o. | 0.75 | GM | 190,57 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 142.9 | J05AB11 | valaciklovir | p.o. | 3.00 | GM | 190,57 | P |
Léčbu ganciklovirem a valganciclovirem předepisuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
- a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,
- b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,
- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
| 142.10 | J05AB12 | cidofovir | parent. | 375.00 | MG | 27 001,33 | U/P |
|---|---|---|---|---|---|---|---|
| 142.11 | J05AB14 | valganciklovir | p.o. | 0.90 | GM | 1 899,69 | P |
| 97249 | VALCYTE 450 MG | por tbl flm60x450mg | HLR | D | |||
| --- | --- | --- | --- | --- | |||
| 142.12 | J05AB15 | brivudin | p.o. | 125 | MG | 190,57 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 142.13 | J05AD01 | foskarnet | parent. | 6.50 | GM | 2 938,01 | U/P |
| 142.14 | J05AH01 | zanamivir | inhal. | 20.00 | MG | 118,25 | P |
Zanamivir je indikován v indikaci léčby influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:
-
- děti starší 12 let s cystickou fibrózou, děti s onkologickým onemocněním na imunosupresivní léčbě
-
- dospělí se závažným chronickým plicním či kardiálním onemocněním na trvalé medikaci
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)